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et al., 2000). Validation of the schizoaffective disorder construct 
as distinct from schizophrenia or bipolar disorder requires con-
sideration of measurement domains other than the clinical data 
used to initially defi ne the construct. Neurobiological measure-
ment domains are perhaps most informative about whether 
distinguishing schizoaffective disorder from other psychotic 
and mood disorders successfully “carves nature at its joints.” 
Unfortunately, research is sparse for most domains, non- existent 
for some, and fi ndings have been inconsistent (Kempf et al., 2005; 
Cheniaux et al., 2008). For example, schizoaffective patients have 
better neurocognitive function than schizophrenia patients in 
some studies (Stip et al., 2005; Gruber et al., 2006; Heinrichs 
et al., 2008) but not others (Miller et al., 1996; Evans et al., 1999; 
Fiszdon et al., 2007). Perhaps because defi nitive data supporting 
a pathophysiological boundary between the disorders are lacking, 
schizoaffective and schizophrenia patients are often combined in 
schizophrenia research.
Among the measurement domains for which studies comparing 
schizoaffective disorder and schizophrenia are lacking are event-
related brain potentials (ERP). In particular, despite the fact that 
amplitude reduction of the P300 component of the ERP is one of 
the most replicated neurobiological abnormalities in schizophrenia 
(Jeon and Polich, 2003), no studies have examined whether this 
biomarker is also compromised in schizoaffective disorder.
INTRODUCTION
Kraepelin (1971) distinguished between “dementia praecox” and 
“manic-depressive psychosis” based on his observations that these 
two groups of psychotic patients exhibited different clusters of 
symptoms and courses of illness. This distinction has persisted in 
psychiatric nosology, underlying the current diagnostic categories 
of schizophrenia and major mood disorders. However, it has long 
been recognized that some patients exhibit symptoms from both 
diagnostic categories, fueling debate about how to classify them and 
where to draw the diagnostic boundaries between schizophrenia 
and psychotic mood disorders (i.e., bipolar disorder and psychotic 
depression). The term “schizoaffective psychosis” was fi rst proposed 
by Kasanin (1933) to describe these patients and it has survived 
to the present.
Whether schizoaffective disorder is a distinct clinical entity 
(Tsuang, 1991; Kasanin, 1933; Kendler et al., 1995), a variant 
of schizophrenia (Williams and McGlashan, 1987; Evans et al., 
1999) or major mood disorders (Lake and Hurwitz, 2007), or the 
refl ection of an underlying continuum between them (Peralta and 
Cuesta, 2008), is still debated (Evans et al., 1999; Kempf et al., 
2005; Cheniaux et al., 2008; Peralta and Cuesta, 2008). The issue 
is obscured by clinical heterogeneity within the schizoaffective 
category (Levitt and Tsuang, 1988), and its diagnostic unreliabil-
ity among clinicians (Maj et al., 2000) and over time (Schwartz 
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P300, a positive voltage defl ection in the ERP occurring approx-
imately 300 ms after stimulus onset, refl ects neurophysiological 
processes associated with processing infrequent target, novel, or 
otherwise salient stimuli. P300 amplitude is thought to refl ect atten-
tional resource allocation (Isreal et al., 1980; Kramer and Strayer, 
1988; Polich, 1989), phasic attentional shifts (Soltani and Knight, 
2000), working memory updating of stimulus context (Johnson, 
1986; Donchin and Coles, 1988), or stimulus salience (Sutton 
et al., 1965, 1967). Its latency is thought to refl ect processing speed 
or effi ciency during stimulus evaluation (Duncan-Johnson and 
Donchin, 1977).
Two subtypes of P300 are distinguished based on the type 
of deviant stimulus used to elicit it. P3b is the P300 elicited 
by infrequent task-relevant target stimuli in “oddball” tasks. It 
refl ects top-down allocation of attentional resources to task-
 relevant events, and has a parietal scalp maximum. P3b amplitude 
reduction and latency delay in schizophrenia are established fi nd-
ings (Ford, 1999; Jeon and Polich, 2003). Cross-sectional studies 
often show P300 reduction to be associated with greater negative 
symptoms (Pfefferbaum et al., 1989; Mathalon et al., 2000a). In a 
longitudinal study, P3b amplitude tracked fl uctuations in posi-
tive symptoms, although it remained abnormally reduced even 
when symptom severity diminished (Mathalon et al., 2000a). 
In addition, P3b is smaller and later in patients with longer ill-
ness durations (Mathalon et al., 2000b), suggesting it may also 
track illness progression. P3a is the P300 elicited by infrequent 
task-irrelevant deviant or distractor stimuli, which are typically 
either novel or otherwise salient, in oddball tasks. It refl ects 
“ bottom-up” orienting of attentional resources to these stimuli 
and has a fronto-central scalp maximum. Although few studies 
have examined P3a in schizophrenia, limited evidence suggests 
its amplitude is also reduced (Pfefferbaum et al., 1989; Mathalon 
et al., 2000a). In our longitudinal study, P3a also tracked clini-
cal severity fl uctuations but did not normalize when patients 
were most remitted (Mathalon et al., 2000a). Although not often 
directly compared, P300 abnormalities in schizophrenia are usu-
ally more prominent in the auditory than visual modality (Jeon 
and Polich, 2003).
Our primary aim was to examine whether P300 amplitude and 
latency elicited by target and task-irrelevant distractor stimuli in 
auditory and visual oddball tasks show differential sensitivity to 
schizophrenia. These four types of P300 (target vs. task-irrelevant 
distractor stimulus, auditory vs. visual modality) have never been 
directly compared within a single study of patients with schizophre-
nia. In addition to schizophrenia patients, we also recruited patients 
with schizoaffective disorder, providing an opportunity to assess 
whether they would show the same pattern of P300 abnormalities 
exhibited by schizophrenia patients.
MATERIALS AND METHODS
PARTICIPANTS
Electroencephalography (EEG) recordings were acquired from 
patients with schizophrenia (SZ; n = 22) and schizoaffective dis-
order (SA; n = 15), as well as healthy comparison subjects (HC; 
n = 22). All gave written informed consent after procedures had 
been fully described. Institutional Review Boards at the West Haven 
VA and Yale University approved this study.
Patients were recruited from community mental health centers 
and outpatient services of the VA Connecticut Healthcare System. 
Also, some patients were recruited by Dr. Hoffman to participate 
in a repetitive transcranial magnetic stimulation (rTMS) clinical 
trial for auditory hallucinations, in which case they were stud-
ied before initiating rTMS treatment. All but one patient were 
on stable doses of antipsychotic medications and met DSM-IV 
(American Psychiatric Association, 1994) criteria for schizophre-
nia or schizoaffective disorder based on a Structured Clinical 
Interview for DSM-IV (SCID) (First et al., 1995). Patients with 
DSM-IV alcohol or drug abuse in the 30 days preceding the study 
were excluded.
HC subjects were recruited by newspaper advertisements and 
word-of-mouth, screened by telephone using questions from 
the SCID (First et al., 1995) non-patient screening module, and 
excluded for any history of Axis I psychiatric illness. All participants 
were excluded for signifi cant head injury, neurological disorders, or 
medical illnesses compromising the central nervous system.
TASKS
In the 3-stimulus auditory oddball task, a random series of infre-
quent (15%) “target” high tones (1000 Hz), frequent (70%) “stand-
ard” low tones (500 Hz), and infrequent task-irrelevant distractor 
sounds (15%), were presented with a 1.25-s stimulus onset asyn-
chrony. Distractor sounds were selected from a corpus of novel 
sounds developed by Friedman (Friedman et al., 1993). The tones 
were 50 ms in duration and 80 dB SPL (C scale). Distractor sounds 
ranged between 175–250 ms in duration and averaged 80 dB SPL 
(C scale).
In the 3-stimulus visual oddball task, an infrequent (15%) target 
stimulus (a plus sign, “+”), a frequent (70%) standard stimulus 
(a minus sign, “−”), and an infrequent (15%) distractor salient 
stimulus (a large blue square), were presented for 500 ms in a ran-
dom sequence with a 1.25-s stimulus onset asynchrony.
In each task, subjects were asked to press a response key to 
the target stimulus. Each task comprised 3 runs of 100 stimuli, 
resulting in 45 targets, 45 distractor stimuli, and 210 standards for 
each modality.
MEASURES
EEG acquisition and pre-processing
Subjects sat in an acoustically shielded booth in front a computer 
monitor and wore insert earphones. EEG was recorded at 1000 Hz 
from 26 scalp sites, bandpass fi ltered between 0.05–100 Hz, and 
referenced to linked ears. Additional electrodes were placed at 
the outer canthi of both eyes and above and below the left eye 
to record eye movements and blinks (vertical and horizontal 
electro-oculogram [EOG]; VEOG, HEOG). All electrode imped-
ances were maintained at or below 10 kOhm, with most EEG sites 
near 5 kOhm.
EEG data from 15 central sites were analyzed (F7, F3, Fz, F4, F8, 
T3, C3, Cz, C4, T4, T5, P3, Pz, P4, T6). Continuous data were sepa-
rated into 1000 ms epochs time-locked to stimulus onset, with a 
100-ms pre-stimulus baseline. VEOG and HEOG data were used to 
correct EEG for eye movements and blinks with a regression-based 
algorithm (Gratton et al., 1983). After baseline correction, epochs 
containing artifacts (voltages exceeding ±100 µV) were rejected.
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Because P300s elicited by auditory and visual stimuli peak at 
different latencies, and because target P3b and distractor P3a have 
different topographies, different rules were used for identifying 
peaks. Auditory P300 was identifi ed as the most positive peak in a 
235–400 ms time window following stimulus onset, whereas visual 
P300 was identifi ed within a 230–500 ms window. Target P3b peak 
was fi rst identifi ed at Pz, then a 50-ms window (±25 ms) surround-
ing this peak’s latency was used to identify target P3b peaks at other 
sites. Distractor P3a showed more scalp variability in peak latency 
than target P3b, particularly at frontal sites, leading us to adopt a 
more fl exible peak identifi cation strategy. Distractor P3a peaks were 
fi rst identifi ed at all central and parietal sites. From the range of 
peak latencies obtained at central sites (T3, C3, Cz, C4, T4), mini-
mum and maximum latencies were identifi ed. By subtracting 50 ms 
from the minimum and adding 50 ms to the maximum, the search 
window for identifi cation of P3a peaks at frontal sites was defi ned. 
The somewhat early latency cut-off (400 ms) for auditory P300s 
was chosen to avoid picking the second late positive component, 
which peaked around 550 ms (see Figure 1). Peak amplitudes were 
used for all P300 measures.
Clinical and demographic measures
Symptoms were rated by trained interviewers using the Positive 
and Negative Symptom Scale (PANSS) (Kay et al., 1987), yielding 
summary severity measures for all (PANSS General), positive 
(PANSS Positive) and negative (PANSS Negative) symptoms. 
Illness duration was calculated based on the age of illness onset 
estimate from the SCID. Parental socioeconomic status (SES) 
was assessed using the Hollingshead scale (Hollingshead and 
Redlich, 1958) with higher scores indicating lower parental SES. 
Demographic and clinical data for all groups are summarized 
in Table 1.
STATISTICAL ANALYSIS
Analysis of variance
Accuracy (percent correct) was analyzed in a 3-way Group (SZ, 
SA, HC) × Deviant Type (Target, Distractor) × Modality (Auditory, 
Visual) analysis of variance (ANOVA). Accuracy for distractor 
stimuli refl ected withholding a response, such that a subject who 
never false-alarmed to distractor stimuli was 100% correct. Subject 
median reaction times (RT) to targets were analyzed in a 2-way 
Group × Modality ANOVA.
P300 amplitudes were analyzed in three ANOVAs, one for 
midline sites (Fz, Cz, Pz), and two for off-midline sites to assess 
for hemispheric laterality effects. The midline ANOVA included 
factors for Group (SZ, SA, HC), Deviant Type (Target, Distractor), 
Modality (Auditory, Visual) and Anterior-Posterior Site (AP: 
Frontal, Central, Parietal). The two off-midline ANOVAs each 
included factors for Group, Deviant Type, Modality, AP, and 
Hemisphere (Left, Right), but different lateral sites defi ned the 
Table 1 | Sample demographic and clinical characteristics.
Variable and ANOVA
  Healthy control (HC) subjects  Schizophrenia patients (SZ) Schizoaffective (SA) patients
Group effect P-value
 n = 22 n = 22 n = 15
 Mean SD Min Max Mean SD Min Max Mean SD Min Max
Age (years) p = 0.61 37.29 12.62 23 59 39.95 10.75 22.00 56.12 36.46 10.05 21.35 54.99
Education (years)****
 p < 0.0001; NC > SZ*,
 NC > SA*, SZ = SA 16.23 2.28 12.0 20.0 12.68 2.14 8.00 16.00 13.90 2.02 11.00 18.00
Average parental
socioeconomic status
 p = 0.43 34.61 15.16 11.0 62.0 39.69 15.30 11.00 73.50 31.70 15.30 11.00 63.50
Mean symptom scores
 PANSS positive p = 0.10     17.15 4.37 12.00 25.00 15.00 4.77 7.00 25.00
 PANSS negative p < 0.06     15.84 4.68 9.00 22.00 12.50 4.56 7.00 22.00
 PANSS general p = 0.03 (SZ > SA)    33.63 8.00 20.00 54.00 27.53 7.21 17.00 42.00
 PANSS anxiety p = 0.69     2.73 1.33 1.00 5.00 2.80 1.37 1.00 5.00
 PANSS depression p = 0.17     2.79 1.22 1.00 5.00 2.20 1.21 1.00 5.00
 PANSS hallucinations p = 0.71    3.87 1.93 1.00 6.00 3.66 1.23 1.00 5.00
 PANSS delusions p = 0.04 (SZ > SA)    3.05 1.43 1.00 6.00 2.00 1.41 1.00 5.00
Handedness***** 19 right, 2 left, 1 ambidextrous 21 right, 1 left 14 right, 1 ambidextrous
Gender 9 women, 13 men 5 women, 17 men 4 women, 11 men
Diagnosis subtype***  3 Undifferentiated, 19 Paranoid 10 Depressed, 5 Bipolar
Age at illness onset** p = 0.29  20.63 3.15 17.00 28.00 23.29 10.07 12.00 42.00
Duration of illness** p = 0.12 18.28 10.80 2.00 36.00 12.78 8.34 1.35 26.00
Antipsychotic medication type 18 atypical, 1 typical, 3 both  15 atypical
*p < 0.05 with Scheffe test, **Missing data for 3 SZ and 1 SA patients, ***Missing subtype diagnosis for 2 SZ patients, ****Missing education data from 2 SA 
patients, *****Missing handedness data from 1 SZ patient.
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hemisphere effect in each ANOVA. In one, far lateral sites defi ned 
a Lateral Hemisphere factor (Lateral Left: F7, T3, P5; Lateral Right: 
F8, T4, P6). In the other, more medial off-midline sites defi ned a 
Medial Hemisphere factor (Medial Left: F3, C3, P3; Medial Right: 
F4, C4, P4).
P3b and P3a peak latencies for target and distractor stimuli 
were only measured at Pz and Cz, respectively, because that is 
where each type of P300 was largest and where its peak latency 
was likely to be most accurate. P300 latencies were analyzed in a 
3-way Group × Deviant Type × Modality ANOVA.
Interactions were parsed using lower order ANOVAs. Differences 
between groups were assessed with least squares differences (LSD) 
post-hoc tests.
Hierarchical multiple regression
Relationships of P300 with clinical and demographic variables 
were evaluated using hierarchical multiple regression models in 
which P300 amplitude was regressed on the Clinical/Demographic 
Variable and Diagnosis (SZ versus SA) simultaneously entered into 
the model at Step 1, and the Diagnosis × Clinical/Demographic 
Variable interaction added to the model at Step 2. When the 
interaction, refl ecting group differences in the slope of the P300-
 clinical/demographic variable regression line, was not signifi cant, 
only regression results at Step 1 were considered, providing tests 
of (a) the relationship between the clinical/demographic variable 
and P300 and (b) diagnostic differences in P300 controlling for the 
clinical/demographic variable. These analyses were limited to target 
P3b measured at Pz and distractor P3a measured at Cz.
Mann–Whitney U-tests
Non-parametric Mann–Whitney U-tests were performed to 
compare P300 amplitudes in the SA-Bipolar Type (n = 10) and 
SA-Depressive Type (n = 5) subgroups. These tests were done 
separately for each modality and deviant type, using the Pz elec-
trode for target P3b and the Cz electrode for distractor P3a. Non-
parametric tests were deemed more appropriate than parametric 
tests for these analyses because of the small size of these two 
patient subgroups.
RESULTS
BEHAVIORAL DATA
Percent correct
ANOVA results are summarized in Table 2. There was a signifi -
cant main effect of Group, with post-hoc tests showing that while 
SZ (94.4%) and SA (93.1%) groups did not differ, both were 
signifi cantly (p < 0.002) less accurate than the HC group (98.5%). 
A signifi cant Modality effect, which did not interact signifi cantly 
with Group, indicated that subjects were more accurate during 
the visual (96%) than the auditory (94%) task. A signifi cant 
Deviant Type effect indicated that subjects committed fewer false 
alarm errors to distractor stimuli than omission errors to tar-
gets. A signifi cant Deviant Type × Group interaction was parsed 
with sub-ANOVAs within each group; the Deviant Type effect 
on accuracy was greater in the SZ (distractor: 98% versus tar-
get: 91%; p = 0.02) and SA (distractor: 95% versus target: 91%; 
p = 0.04) groups than in the HC group (distractor: 99% versus 
target: 98%; p = 0.63).
Reaction times to targets
As presented in Table 2, there was a signifi cant Group effect, with 
HC (332 ms) responding more quickly than SZ (400 ms; p < 0.001) 
or SA (379 ms; p = 0.01) groups. RTs in the two patient groups did 
not differ (p = 0.24). Modality and Group × Modality effects were 
not signifi cant.
ERP DATA
Group overlays of the grand average ERP waveforms and maps of 
their corresponding scalp topographies, in which the P300 compo-
nent is evident as a large positive wave peaking around 300 ms, are 
shown separately for each Deviant Type and Modality in Figure 1. 
ANOVA results for P300 amplitude and latency conducted for 
midline electrodes, and results of the two off-midline ANOVAs 
assessing Medial and Lateral Hemisphere effects, respectively, are 
summarized in Table 2.
Midline analysis
There was a signifi cant Group effect on P300 amplitude at midline 
sites (see Table 2). Post-hoc tests showed SZ to have smaller P300 
amplitudes than either HC (p < 0.0001) or SA (p < 0.001) groups, 
but HC and SA groups did not signifi cantly differ. Importantly, 
Group did not signifi cantly interact with Deviant Type or Modality 
(see Figure 2).
A signifi cant Modality effect on P300 amplitude indicated that 
visual P300s (12.8 µV) were larger than auditory P300s (8.6 µV). 
Deviant Type did not signifi cantly affect P300 amplitude (tar-
get P300s = 10.5 µV; distractor P300s = 10.9 µV). Although the 
Modality × Deviant Type interaction was not signifi cant, a signifi cant 
higher-order Modality × Deviant Type × AP interaction emerged. 
To parse this interaction, the Deviant Type × AP interaction was 
assessed separately for auditory and visual modalities. Although 
the Deviant Type × AP interaction was signifi cant in both modali-
ties, it was stronger for auditory [F(2,112) = 113.5, p < 0.0001] than 
for visual [F(2,112) = 52.6, p < 0.0001] P300s. In both modalities, 
distractor stimuli elicited a P300 with a central maximum typical of 
P3a scalp topography, whereas target stimuli elicited a P300 with a 
parietal maximum typical of P3b topography (see Figure 1).
Off-midline analysis
Because schizophrenia patients sometimes have smaller P300s 
over left than right temporal sites (McCarley et al., 1991), our 
focus in the off-midline analyses was only on effects  involving 
Group × Hemisphere interactions. None of these effects was 
 signifi cant for the medial or lateral hemisphere ANOVAs (see 
Table 2). Other signifi cant hemisphere effects, which only emerged 
for the medial hemisphere sites, are not described further because 
they were not germane to our study aims.
P300 latency
There was a signifi cant Group effect on P300 latency, with HC hav-
ing an earlier P300 (333 ms) than SZ (355 ms) and SA (352 ms) 
groups (see Table 2). Signifi cant main effects for Deviant Type and 
Modality indicated that P300 was later to target (361 ms) than dis-
tractor (333 ms) stimuli and later to visual (375 ms) than auditory 
(319 ms) stimuli, respectively. Group did not interact signifi cantly 
with Deviant Type or Modality.
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Table 2 | ANOVA summaries.
Source Median RT Percent correct Median P300 latency
 df F p-value* F p-value F p-value
Group 2,56 9.37 0.0001** 7.13 0.002*** 3.90 0.03****
Deviant Type 1,56   13.3 0.001 26.90 0.0001
Deviant Type × Group 2,56   3.193 0.05 2.00 0.15
Modality 1,56 1.067 0.306 3.929 0.05 91.13 0.0001
Modality × Group 2,56 1.055 0.355 0.687 0.51 0.02 0.98
Deviant Type × Modality 1,56   0.017 0.90 1.01 0.32
Deviant Type × Modality × Group 2,56   0.273 0.76 0.13 0.88
 P300 Amplitude    Source
 Midline Site
 Analysis (Fz, Cz, Pz)
 df F p-value
Group 2,56 9.11 0.0001    
Deviant Type 1,56 0.89 0.35    
Deviant Type × Group 2,56 1.48 0.24    
Modality 1,56 69.47 0.0001    
Modality × Group 2,56 1.36 0.27    
AP***** 2,112 72.61 0.0001    
AP × Group 4,112 0.91 0.44    
Deviant Type × Modality 1,56 0.26 0.61    
Deviant Type × Modality × Group 2,56 1.61 0.21    
Deviant Type × AP 2,112 101.80 0.0001    
Deviant Type × AP × Group 4,112 0.93 0.43    
Modality × AP 2,112 9.93 0.0001    
Modality × AP × Group 4,112 0.19 0.91    
Deviant Type × Modality × AP 4,112 4.81 0.01    
Deviant Type × Modality × AP × Group 4,112 1.13 0.35    
 P300 Amplitude Medial  P300 Amplitude LateralSource
 Hemisphere Analysis Hemisphere Analysis
 (F3, F4, C3, C4, P3, P4) (F7, F8, T3, T4, C5, C6)
 df F p-value F p-value
Group 2,56 9.48 0.0001 7.59 0.001  
Deviant Type 1,56 0.10 0.75 0.48 0.49  
Deviant Type × Group 2,56 1.28 0.29 0.51 0.60  
Modality 1,56 96.78 0.0001 79.90 0.0001  
Modality × Group 1,56 1.79 0.18 0.53 0.59  
AP 2,112 62.40 0.0001 40.06 0.0001  
AP × Group 4,112 0.60 0.59 0.59 0.58  
Hemisphere 1,56 12.31 0.001 2.86 0.10  
Hemisphere × Group 2,56 1.20 0.31 1.48 0.24  
Deviant Type × Modality 1,56 0.49 0.49 0.23 0.64  
Deviant Type × Modality × Group 2,56 1.08 0.35 0.16 0.86  
Deviant Type × AP 2,112 61.31 0.0001 20.48 0.0001  
Deviant Type × AP × Group 4,112 0.87 0.46 0.62 0.60  
Deviant Type × Hemisphere 2,112 14.54 0.0001 0.57 0.46  
Deviant Type × Hemisphere × Group 4,112 0.94 0.40 1.54 0.22  
Modality × AP 2,112 5.52 0.02 1.56 0.22  
Modality × AP × Group 4,112 0.42 0.70 1.49 0.23  
Modality × Hemisphere 1,56 0.05 0.83 0.11 0.74  
(Continued)
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Modality × Hemisphere × Group 2,56 1.75 0.18 0.77 0.47  
AP × Hemisphere 2,112 7.85 0.002 7.92 0.002  
AP × Hemisphere × Group 4,112 0.44 0.72 0.29 0.83  
Deviant Type × Modality × AP 2,112 14.70 0.0001 38.07 0.0001  
Deviant Type × Modality × AP × Group 4,112 0.80 0.50 1.44 0.24  
Deviant Type × Modality × Hemisphere 1,56 1.66 0.20 1.51 0.22  
Deviant Type × Modality × Hemisphere × Group 2,56 1.18 0.31 0.57 0.57  
Modality × AP × Hemisphere 2,112 9.93 0.0001 2.80 0.08  
Modality × AP × Hemisphere × Group 4,112 0.11 0.96 0.51 0.68  
Deviant Type × Modality × AP × Hemisphere 2,112 1.12 0.33 2.28 0.11  
Deviant Type × Modality × AP × Hemisphere × Group 4,112 1.54 0.20 0.97 0.42  
*Probability value based on Greenhouse-Geisser correction.
**Group: HC < SZ (p = 0.005), HC < SA (p = 0.001), SZ = SA (p = 0.43), ***Group: HC > SZ (p < 0.0001), HC > SA (p = 0.01), SZ = SA (p = 0.24), ****Group: 
HC < SZ (0.01), HC < SA (p = 0.045), SZ = SA (p = 0.76), *****AP = Anterior-Posterior (frontal, central, parietal).
Tables 2 | (Continued)
 P300 Amplitude Medial  P300 Amplitude LateralSource
 Hemisphere Analysis Hemisphere Analysis
 (F3, F4, C3, C4, P3, P4) (F7, F8, T3, T4, C5, C6)
 df F p-value F p-value
P300 relationships with clinical and demographic variables
Results of hierarchical multiple regression analyses conducted to 
assess the effects of clinical or demographic variables, diagnosis (SZ 
versus SA), and their interaction, on P300 amplitude are presented 
in Table 3.
SZ patients had more severe symptoms than SA patients 
for PANSS General [t(32) = −2.31, p = 0.028], PANSS Positive 
Symptoms (trend level only: [t(32) = −1.86, p = 0.072], and PANSS 
Negative Symptoms [t(32) = −2.09, p = 0.044]. At step 2, no signifi -
cant group differences in the slopes of the P300-PANSS Severity 
score relationships emerged for any of the P300s examined. At step 
1, none of the PANSS Severity scores were signifi cantly related to 
P300 amplitude, and SZ continued to exhibit smaller P300s than SA 
patients (signifi cant Diagnosis effect) for all but the visual targets 
(which showed a trend).
The patient groups did not differ in illness duration 
[t(31) = −1.58, p = 0.12]. At step 2, the slopes of the relationship 
between illness duration and P300 amplitude signifi cantly differed 
for the two groups only for P300 elicited by auditory target and 
visual distractor stimuli. The difference in slopes refl ected relatively 
steeper declines in P300 amplitude with increasing illness duration 
in the SA group (auditory target P300: r = −0.51, p = 0.06; visual 
distractor P300: r = −0.72, p = 0.004) but not in the SZ group. As 
shown in Figure 3, larger P300 amplitude in SA, relative to SZ, 
patients was particularly evident early in the illness course. At step 1, 
P300s elicited by visual target and auditory distractor stimuli were 
not signifi cantly related to illness duration. Moreover, SZ continued 
to exhibit smaller P300 than SA patients for auditory distractor 
stimuli, but not for visual targets (which showed a trend).
The patient groups had similar parental SES (p = 0.25). At step 
2, the slopes of the relationship between parental SES and P300 
amplitude were not signifi cantly different for any of the types of 
P300. At step 1, parental SES was not signifi cantly related to P300 
amplitude. Controlling for parental SES, P300 amplitudes were 
smaller in SZ than SA patients for auditory target and visual dis-
tractor stimuli, with similar trends evident for visual target and 
auditory distractor stimuli.
The patient groups did not differ in years of education (p = 0.12). 
At step 2, the slopes of the relationship between education and P300 
amplitude were signifi cantly different in the two groups only for 
visual targets. This arose because in SA, but not SZ, patients, fewer 
years of education were associated with larger P300s. At step 1, 
this inverse relationship between years of education and P300 was 
evident in both groups for visual distractor stimuli, with a similar 
trend for auditory targets. Since these inverse relationships were 
somewhat paradoxical and are not relevant to our study aims, they 
are not discussed further. Importantly, after accounting for these 
education-P300 relationships at Step 1, P300 was still signifi cantly 
reduced in SZ relative to SA patients.
When the 4 SZ patients taking typical antipsychotics were 
excluded, P300 amplitudes continued to be signifi cantly smaller 
in the SZ than the SA group.
Comparison of schizoaffective disorder subtypes
Mann–Whitney U-tests comparing the SA-Bipolar Type (n = 10) 
and SA-Depressed Type (n = 5) subgroups found no signifi cant 
group differences in P300 amplitude, regardless of which deviant 
type or sensory modality was examined.
DISCUSSION
This is the fi rst ERP study to directly compare schizoaffective disorder 
and schizophrenia. Surprisingly, schizoaffective disorder patients did 
not exhibit abnormally reduced P300 amplitudes, despite signifi cant 
P300 reduction in schizophrenia patients  evident in both the present 
study and numerous prior studies (Ford, 1999; Jeon and Polich, 
2003). This suggests that the neurophysiological mechanisms sup-
porting attentional resource allocation to infrequent stimuli, whether 
they be task relevant targets or task-irrelevant distractors, are intact 
in schizoaffective disorder but impaired in schizophrenia.
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FIGURE 1 | Grand average ERPs (top row) and P300 scalp topography 
maps for Auditory and Visual Targets (far left and mid-left columns, 
respectively) and Auditory and Visual Task-Irrelevant Distractors (mid-
right and far right columns, respectively) in healthy controls (HC; second 
row), patients with schizoaffective disorder (SA; third row) and patients 
with schizophrenia (SZ; fourth row). Latency windows capturing the P300 
for each condition and group are indicated below each topographic map. The 
color-coding on the scalp topography maps refl ects voltage for that group at 
that site. In the grand average plots, target ERPs are plotted from electrode Pz 
and task-irrelevant distractor ERPs are from Cz. ERPs are overlaid for HC 
(green tracings), SA (red tracings) and SZ (blue tracings) groups. Time is shown 
on the x-axis and voltage on the y-axis. Voltage scales are different for the 
different stimulus types. Positivity relative to the reference electrodes is 
plotted up.
This fi nding adds to a very sparse research literature examining 
neurobiological distinctions between schizophrenia and schizoaf-
fective disorder (Evans et al., 1999; Kempf et al., 2005; Cheniaux 
et al., 2008; Peralta and Cuesta, 2008) and provides striking data 
in support of this distinction. In interpreting the P300 amplitude 
group differences observed in our study, it is important to note 
that the two patient groups showed similar defi cits on speed and 
accuracy of responding and similar prolongation of P300 latency. 
They also had similar backgrounds in terms of education and 
parental socioeconomic status. Moreover, despite the tendency for 
the schizophrenia patients to have more severe symptoms than 
the schizoaffective disorder patients, the group differences in P300 
amplitude persisted when these clinical and demographic measures 
were taken into account.
Although the groups did not differ in illness duration, the schizoaf-
fective patients had particularly large auditory P3b and visual P3a 
amplitudes earlier in their illness course, relative to schizophrenia 
patients with similarly short illness durations. This is consistent 
with data showing schizoaffective disorder to be associated with a 
better premorbid adjustment than schizophrenia (Saracco-Alvarez 
et al., 2009). Subsequent P300 reduction due to illness progression 
appears to occur at a faster rate in schizoaffective disorder than in 
schizophrenia, at least for auditory P3b and visual P3a.
One of the hypotheses often subscribed to by clinical researchers 
is that the depressive type of schizoaffective disorder is more closely 
related to schizophrenia, whereas the bipolar type of schizoaffective 
disorder is more closely related to mood disorders. This distinction 
has received limited and somewhat inconsistent empirical support 
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FIGURE 2 | Means for P300 amplitudes from Fz, Cz, and Pz are plotted for 
Auditory Targets (upper left), Auditory Task-Irrelevant Distractors (lower 
left), Visual Targets (upper right) and Visual Task-Irrelevant Distractors 
(lower right). Color-coding is the same as in Figure 1.
analysis of this question was limited by the small sample size of the 
depressed type subgroup, the data from the present study showed 
no signifi cant, or even trend level, difference in P300 amplitude 
between the two subtypes of schizoaffective patients.
Although this is the fi rst study to explicitly examine the dif-
ference in P300 between schizophrenia and schizoaffective disor-
der based on the application of current diagnostic criteria, prior 
studies by Strik et al. (1993) have documented normal or even 
enhanced P300 (Strik et al., 1997) amplitudes in patients who 
met criteria for cycloid psychosis, a psychotic disorder clinically 
distinguished from schizophrenia based on Leonhard’s diagnos-
tic classifi cation system that has been infl uential in European 
psychiatry. The current fi ndings are complementary to, rather 
than replicative of, Strik’s earlier studies since cycloid psychosis 
is not clinically synonymous with current defi nitions of schizoaf-
fective disorder (Vogl and Zaudig, 1985; Zaudig, 1990; Peralta 
et al., 2007). Nonetheless, both sets of fi ndings underscore the fact 
that, despite the commonly held view that P300 amplitude reduc-
tion is a relatively non-specifi c electrophysiological abnormality 
observed in a number of psychiatric disorders, it may nonethe-
less be useful in demarcating or validating diagnostic bounda-
ries within the clinical heterogeneity encompassed by chronic 
psychotic disorders. At least within these murky waters, P300 
amplitude reduction may be relatively specifi c to schizophrenia. 
While the intact P300 amplitudes in observed in patients with 
schizoaffective disorder in the present study does not prove that 
Table 3 | Multiple regression of P300 on clinical/demographic variables and diagnosis (schizophrenia versus schizoaffective disorder).
Model
  
Regressor Variable
 Targets  Task-Irrelevant distractors
 Auditory P300 (P3b) at Pz Visual P300 (P3b) at Pz Auditory P300 (P3a) at Cz Visual P300 (P3a) at Cz 
  Step  Beta  p-value Step Beta  p-value Step  Beta  p-value Step  Beta  p-value
  entered  at step  entered at step  entered at step  entered at step
1 PANSS General (PG) 1 0.10 0.58 1 0.08 0.65 1 0.21 0.23 1 −0.18 0.28
 Diagnosis (DX) 1 −0.50 0.007 1 −0.35 0.067 1 −0.45 0.016 1 −0.40 0.024
 PG × DX  2 0.30 0.71 2 −0.10 0.91 2 −0.74 0.36 2 −0.47 0.54
2 PANSS Positive (PP) 1 0.21 0.21 1 0.13 0.48 1 0.05 0.78 1 0.05 0.78
 Diagnosis (DX) 1 −0.53 0.003 1 −0.36 0.054 1 −0.39 0.036 1 −0.48 0.007
 PP × DX 2 0.22 0.74 2 −0.05 0.94 2 0.00 0.99 2 −0.46 0.49
3 PANSS Negative (PN) 1 0.11 0.52 1 −0.03 0.86 1 0.09 0.62 1 0.07 0.69
 Diagnosis (DX) 1 −0.50 0.006 1 −0.31 0.10 1 −0.40 0.031 1 −0.49 0.007
 PN × DX 2 −0.13 0.84 2 0.11 0.88 2 0.90 0.17 2 0.19 0.77
4 Illness Duration (ID) 1 −0.18 0.27 1 −0.22 0.22 1 −0.14 0.42 1 −0.26 0.09
 Diagnosis (DX) 1 −0.44 0.012 1 −0.30 0.096 1 −0.41 0.022 1 −0.47 0.005
 ID × DX 2 0.83 0.053 2 0.67 0.15 2 0.23 0.61 2 0.91 0.02
5 Parental Socioeconomic 
 Status (PSS) 1 −0.19 0.23 1 −0.31 0.061 1 −0.13 0.46 1 −0.13 0.41
 Diagnosis (DX) 1 −0.44 0.009 1 −0.29 0.080 1 −0.34 0.054 1 −0.50 0.003
 PSS × DX 2 −0.28 0.58 2 −0.40 0.31 2 0.03 0.96 2 −0.47 0.33
6 Years Education (YE) 1 −0.28 0.072 1 −0.14 0.40 1 0.07 0.66 1 −0.32 0.03
 Diagnosis (DX) 1 −0.60 0.0003 1 −0.44 0.013 1 −0.45 0.009 1 −0.65 0.0001
 YE × DX  2 1.39 0.14 2 2.22 0.033 2 −0.77 0.46 2 0.40 0.66
Bolded p-values indicate signifi cant (p < 0.05) t-tests for beta coeffi cient at step entered.
from family studies and clinical outcome studies (Kendler et al., 
1995; Cheniaux et al., 2008). This led us to examine whether the 
normal P300 amplitudes observed in the schizoaffective patients as 
a group obscured a P300 amplitude defi cit evident only within the 
schizoaffective-depressed type subgroup. With the caveat that our 
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FIGURE 3 | Scatterplots showing relationships between Illness Duration 
(years) and P300 amplitude elicited by Visual Task-Irrelevant Distractors 
(right) and Auditory Targets (left) for schizoaffective patients (red) and 
schizophrenia patients (blue).
The initial aim of this study was to directly compare four types 
of P300, namely P3b and P3a elicited in auditory and visual oddball 
paradigms, in terms of their sensitivity to schizophrenia. While 
prior research suggests that auditory P300 is more sensitive to 
schizophrenia than visual P300 (Ford, 1999; Jeon and Polich, 2003), 
and that the top-down attentional processes refl ected by target 
P3b may be particularly sensitive to schizophrenia’s higher-order 
cognitive defi cits relative to the bottom-up processes contribut-
ing to P3a, these conclusions are mainly derived from studies 
assessing only one or two of the P300 types assessed in our study. 
Surprisingly, direct comparison of all four types of P300 failed to 
support their differential sensitivity to schizophrenia. Instead, our 
results suggest that P300 is reduced and delayed in schizophrenia 
to the same degree, irrespective of the sensory modality and atten-
tional system engaged.
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this disorder is pathophysiologically distinct from schizophrenia, 
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